Evidence map›Paper›PMID 31803813›Full record

ArticleVirusdisease2019

Genotypes II and VIId-based inactivated Newcastle disease vaccine reduces virus shedding.

Nehal K Mahmoud, Ayman H El-Deeb, Mohammed M Emara, M A Abd El-Khaleck, Hussein A Hussein

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Virusdisease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Therapeutic efficacy ofFrontiers in microbiology · 2022
    Article
  6. AvianFrontiers in veterinary science · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nehal K MahmoudDepartment of Newcastle Disease, Veterinary Serum and Vaccine Research Institute, Abbassia, Cairo 11381 Egypt.
Ayman H El-Deeb2Department of Virology, Faculty of Veterinary Medicine, Cairo University, Giza, 12211 Egypt.
Mohammed M Emara2Department of Virology, Faculty of Veterinary Medicine, Cairo University, Giza, 12211 Egypt.
M A Abd El-KhaleckDepartment of Newcastle Disease, Veterinary Serum and Vaccine Research Institute, Abbassia, Cairo 11381 Egypt.
Hussein A Hussein2Department of Virology, Faculty of Veterinary Medicine, Cairo University, Giza, 12211 Egypt.ORCID 0000-0002-5589-1985
Cairo University · EGVeterinary Serum and Vaccine Research Institute · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Egypt, recent outbreaks were reported in NDV-vaccinated flocks. The isolated strain was characterized as class II velogenic genotype VIId of Newcastle disease virus (NDV). In this study, three inactivated NDV vaccine formulations were prepared, the first one is LaSota (genotype II), the second one is genotype VIId and the third one is combined Lasota and genotype VIId at a proportion of 1:1. The challenge trials were conducted in SPF chicks to evaluate the efficacy of the prepared vaccines using 10

Indexed as

Cross protectionNDV genotype VIIdNDV sheddingNeutralization indexReal time PCR

Identifiers

PMID31803813
PMCPMC6864008
OpenAlexW2963362439

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.